Cancer Research AACR Conference on Molecular Diagnostics - 2008  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 56, 1503-1508, April 1, 1996]
© 1996 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Albanell, J.
Right arrow Articles by Moore, M. A. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Albanell, J.
Right arrow Articles by Moore, M. A. S.

Telomerase Activity Is Repressed during Differentiation of Maturation-sensitive but not Resistant Human Tumor Cell Lines1

Juan Albanell, Wei Han, Begoña Mellado, Ru Gunawardane, Howard I. Scher, Ethan Dmitrovsky and Malcolm A. S. Moore2

Laboratories of Developmental Hematopoiesis [J. A., W. H., R. G., M. A. S. M.] and Molecular Medicine [B. M., E. D.] and Genitourinary Oncology Service [E. D., H. I. S.], Memorial Sloan-Kettering Cancer Center, New York, New York 10021

The effects of induced differentiation on telomerase activity were examined in human acute promyelocytic leukemic (NB4) and human embryonal carcinoma (NTERA-2) cells exposed to all-trans-retinoic acid or hexamethylene bisacetamide. Retinoic acid treatment of NB4 and NTERA-2 cells, and hexamethylene bisacetamide treatment of NTERA-2 cells caused a decline in telomerase activity in differentiation-sensitive but not in resistant clones of these cell lines. Changes in telomerase activity as measured by the PCR-based telomeric repeat amplification protocol assay were noted by 24–72 h of exposure to the inducer, suggesting that its regulation may precede terminal differentiation. The degree of telomerase activity decline was greater in NB4 cells than in NTERA-2 cells, probably reflecting in part a more mature state of NB4 cells after 5 days of exposure to the inducer. Mixing of protein extracts from treated and untreated cells did not suggest the presence of diffusible telomerase inhibitors. Expression of the RNA component of telomerase was also examined in NB4 cells, and its decline correlated with the reduced telomerase activity measured by the telomeric repeat amplification protocol assay during induced differentiation of these tumor cells. Taken together, these findings indicate that telomerase is a regulated enzyme system during induced human tumor cell differentiation, showing an inverse relationship between the degree of differentiation and telomerase activity. These models will be useful to study the regulation and role of telomerase during induced differentiation of human tumor cells.

1 This work was supported by NIH Grants U19 CA67842-01 (M. A. S. M.), RO1-CA62275-02 (E. D.), and RO1-CA54494-04A1 (E. D.), the Gar Reichman Fund of the Cancer Research Institute (M. A. S. M.), the Byrne Foundation (M. A. S. M.), American Cancer Society Grant DB-47E (E. D.), the Martin Himmel Fund (H. I. S.), the CaPcure Foundation (H. I. S.), and Fondo de Investigación Sanitaria (Spain) Grants 94/5654 (J. A.) and 95/5641 (B. M.).

2 To whom requests for reprints should be addressed, at Laboratory of Developmental Hematopoiesis, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021.

Received 1/19/96. Accepted 2/13/96.




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
M. Nouzova, N. Holtan, M. M. Oshiro, R. B. Isett, J. L. Munoz-Rodriguez, A. F. List, M. L. Narro, S. J. Miller, N. C. Merchant, and B. W. Futscher
Epigenomic Changes during Leukemia Cell Differentiation: Analysis of Histone Acetylation and Cytosine Methylation Using CpG Island Microarrays
J. Pharmacol. Exp. Ther., December 1, 2004; 311(3): 968 - 981.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
J.-C. Soria, C. Moon, L. Wang, W. N. Hittelman, S. J. Jang, S.-Y. Sun, J. J. Lee, D. Liu, J. M. Kurie, R. C. Morice, et al.
Effects of N-(4-Hydroxyphenyl)retinamide on hTERT Expression in the Bronchial Epithelium of Cigarette Smokers
J Natl Cancer Inst, August 15, 2001; 93(16): 1257 - 1263.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
Z. Lin, S. Lim, M. A. Viani, M. Sapp, and M. S. Lim
Down-Regulation of Telomerase Activity in Malignant Lymphomas by Radiation and Chemotherapeutic Agents
Am. J. Pathol., August 1, 2001; 159(2): 711 - 719.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
C. Chaves-Dias, T. R. Hundley, A. M. Gilfillan, A. S. Kirshenbaum, J. R. Cunha-Melo, D. D. Metcalfe, and M. A. Beaven
Induction of Telomerase Activity During Development of Human Mast Cells from Peripheral Blood CD34+ Cells: Comparisons with Tumor Mast-Cell Lines
J. Immunol., June 1, 2001; 166(11): 6647 - 6656.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. Pendino, M. Flexor, F. Delhommeau, D. Buet, M. Lanotte, and E. Ségal-Bendirdjian
Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation
PNAS, May 18, 2001; (2001) 111464998.
[Abstract] [Full Text]


Home page
Mol Hum ReprodHome page
K. Fukunaka, T. Saito, K. Wataba, K. Ashihara, E. Ito, and R. Kudo
Changes in expression and subcellular localization of nuclear retinoic acid receptors in human endometrial epithelium during the menstrual cycle
Mol. Hum. Reprod., May 1, 2001; 7(5): 437 - 446.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
M. Hou, D. Xu, M. Bjorkholm, and A. Gruber
Real-Time Quantitative Telomeric Repeat Amplification Protocol Assay for the Detection of Telomerase Activity
Clin. Chem., March 1, 2001; 47(3): 519 - 524.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
B.-S. Herbert, A. C. Wright, C. M. Passons, W. E. Wright, I. U. Ali, L. Kopelovich, and J. W. Shay
Effects of Chemopreventive and Antitelomerase Agents on the Spontaneous Immortalization of Breast Epithelial Cells
J Natl Cancer Inst, January 3, 2001; 93(1): 39 - 45.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
T.-S. Yeh, T.-C. Chen, and M.-F. Chen
Dedifferentiation of Human Hepatocellular Carcinoma Up-regulates Telomerase and Ki-67 Expression
Arch Surg, November 1, 2000; 135(11): 1334 - 1339.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
M. V. Achi, N. Ravindranath, and M. Dym
Telomere Length in Male Germ Cells Is Inversely Correlated with Telomerase Activity
Biol Reprod, August 1, 2000; 63(2): 591 - 598.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
Y. Kitagawa, S. Kyo, M. Takakura, T. Kanaya, K. Koshida, M. Namiki, and M. Inoue
Demethylating Reagent 5-Azacytidine Inhibits Telomerase Activity in Human Prostate Cancer Cells through Transcriptional Repression of hTERT
Clin. Cancer Res., July 1, 2000; 6(7): 2868 - 2875.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
T. Kanaya, S. Kyo, K. Hamada, M. Takakura, Y. Kitagawa, H. Harada, and M. Inoue
Adenoviral Expression of p53 Represses Telomerase Activity through Down-Regulation of Human Telomerase Reverse Transcriptase Transcription
Clin. Cancer Res., April 1, 2000; 6(4): 1239 - 1247.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
M. Engelhardt, K. Mackenzie, P. Drullinsky, R. T. Silver, and M. A. S. Moore
Telomerase Activity and Telomere Length in Acute and Chronic Leukemia, Pre- and Post-ex Vivo Culture
Cancer Res., February 1, 2000; 60(3): 610 - 617.
[Abstract] [Full Text]


Home page
JNCI J Natl Cancer InstHome page
J. Albanell, G. J. Bosl, V. E. Reuter, M. Engelhardt, S. Franco, M. A. S. Moore, and E. Dmitrovsky
Telomerase Activity in Germ Cell Cancers and Mature Teratomas
J Natl Cancer Inst, August 4, 1999; 91(15): 1321 - 1326.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. Bednarek, A. Shilkaitis, A. Green, R. Lubet, G. Kelloff, K. Christov, and C. M. Aldaz
Suppression of cell proliferation and telomerase activity in 4-(hydroxyphenyl)retinamide-treated mammary tumors
Carcinogenesis, May 1, 1999; 20(5): 879 - 883.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. W. Greider
Telomerase activity, cell proliferation, and cancer
PNAS, January 6, 1998; 95(1): 90 - 92.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. E. Holt, D. L. Aisner, J. W. Shay, and W. E. Wright
Lack of cell cycle regulation of telomerase activity in human cells
PNAS, September 30, 1997; 94(20): 10687 - 10692.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Engelhardt, R. Kumar, J. Albanell, R. Pettengell, W. Han, and M. A.S. Moore
Telomerase Regulation, Cell Cycle, and Telomere Stability in Primitive Hematopoietic Cells
Blood, July 1, 1997; 90(1): 182 - 193.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. Pendino, M. Flexor, F. Delhommeau, D. Buet, M. Lanotte, and E. Segal-Bendirdjian
Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation
PNAS, June 5, 2001; 98(12): 6662 - 6667.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1996 by the American Association for Cancer Research.